A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales ...

Morgan Stanley believes that Johnson and Johnson has stronger earnings potential driven by its robust product cycle. The bank ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson‘s baby powder was to blame for their ovarian cancer. Erik Haas, Johnson & Johnson‘s worldwide vice president of ...

As Johnson & Johnson seeks city incentives to help expand its Jacksonville-based vision products subsidiary, company officials are touting the growth potential of the unit.

A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the ...

Jessica Dean, of Dallas-based Dean Omar Branham Shirley, talked to Law.com about the $1.5 billion talc verdict that jurors in Baltimore, Maryland, returned on Monday against Johnson & Johnson. The ...

Johnson & Johnson is taking flight with the New York Jets, joining the NFL team’s roster in a multiyear agreement as its official medical innovation sponsor. Under the new sponsorship, unveiled ...

Johnson & Johnson (JNJ) stock gains as Morgan Stanley upgrades the company to Overweight, lifting the price target to $262, ...